Breaking News, Collaborations & Alliances

IONTAS & Sanofi Sign Agreement for Antibody Discovery

Using IONTAS' Mammalian Display Technology

IONTAS Limited has signed an agreement with Sanofi to discover antibodies using IONTAS’ proprietary Mammalian Display Technology.   IONTAS’ platform allows for the construction of large libraries of monoclonal cell lines each displaying a different IgG-formatted antibody on the cell surface. Novel binders can be isolated from the libraries by using fluorescence-activated cell sorting on the basis of antigen binding. The company says that the system also has the potential to identify clon...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters